The Office of Research and Sponsored Programs (ORSP) has received a notice of award from HNB Therapeutics LLC for funding in the amount of $42,232 to support the new project titled “Nanofiber Expanded CD34+ Stem Cells for Osteoporosis Therapy” for the period of February 10, 2020 to June 30, 2020. The original source of funding is the National Institutes of Health.